Barrett & Company’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$36.7K Sell
416
-7
-2% -$599 0.01% 342
2026
Q2
$32.6K Hold
423
– – 0.01% 362
2026
Q1
$27.6K Buy
423
+42
+11% +$3.12K 0.01% 357
2025
Q4
$30.2K Sell
381
-17
-4% -$1.3K 0.01% 350
2025
Q3
$29.1K Hold
398
– – 0.01% 359
2025
Q2
$30.2K Buy
398
+268
+206% +$19K 0.01% 361
2025
Q1
$9.9K Hold
130
– – ﹤0.01% 443
2024
Q4
$8.59K Hold
130
– – ﹤0.01% 442
2024
Q3
$9.06K Hold
130
– – ﹤0.01% 434
2024
Q2
$6.87K Buy
+130
New +$7.89K ﹤0.01% 462

Other funds holding SOLV

Barrett & Company's SOLV Position: Q3 2026 in Review

Barrett & Company reduced its Solventum (SOLV) stake by 1.7% in Q3 2026, selling an estimated $599 and leaving 416 shares worth $36.7K. The position accounts for 0.01% of the portfolio, ranked #342.

Barrett & Company first reported a position in SOLV in Q2 2024 and has held it in 10 quarters since. 897 funds tracked by Wall St. Rank hold SOLV as of Q3 2026.

  • Barrett & Company held 416 shares of Solventum worth $36.7K as of Q3 2026.
  • Barrett & Company sold 7 Solventum shares in Q3 2026, an estimated $599.
  • Solventum made up 0.01% of Barrett & Company's portfolio in Q3 2026, its #342 holding.
  • Barrett & Company first reported a position in Solventum in Q2 2024 and has held it in 10 quarters since.
  • 897 funds tracked by Wall St. Rank held Solventum as of Q3 2026.

Based on Barrett & Company's 13F filing for Q3 2026, filed 22 Oct 2026.